neostigmine has been researched along with Cardiac Death in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| POOLER, HE | 1 |
| Spasov, V | 1 |
| Getova, D | 1 |
| Spasov, A | 1 |
2 other studies available for neostigmine and Cardiac Death
| Article | Year |
|---|---|
Atropine, neostigmine and sudden deaths.
Topics: Atropine; Death; Death, Sudden; Humans; Neostigmine | 1957 |
[Comparison of 2-aminopyridine, 3-aminopyridine and 4-aminopyridine hydrochlorides and iodomethylates by the degree of decrease in curare toxicity].
Topics: Aminopyridines; Animals; Apnea; Curare; Death; Dose-Response Relationship, Drug; Galantamine; Hydroc | 1979 |